INVO Bioscience, Inc. (INVO)
- Previous Close
1.2400 - Open
1.1900 - Bid 1.0600 x 100
- Ask 1.1500 x 100
- Day's Range
1.0000 - 1.2399 - 52 Week Range
0.5000 - 3.5000 - Volume
2,772,698 - Avg. Volume
1,046,968 - Market Cap (intraday)
4.336M - Beta (5Y Monthly) 1.44
- PE Ratio (TTM)
1.61 - EPS (TTM)
0.6900 - Earnings Date Nov 11, 2024 - Nov 15, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
www.invobioscience.comRecent News: INVO
View More
Performance Overview: INVO
Trailing total returns as of 10/15/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INVO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INVO
View MoreValuation Measures
Market Cap
4.78M
Enterprise Value
16.72M
Trailing P/E
1.77
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.59
Price/Book (mrq)
--
Enterprise Value/Revenue
2.90
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-122.80%
Return on Assets (ttm)
-26.57%
Return on Equity (ttm)
--
Revenue (ttm)
5.77M
Net Income Avi to Common (ttm)
-7.08M
Diluted EPS (ttm)
0.6900
Balance Sheet and Cash Flow
Total Cash (mrq)
942.93k
Total Debt/Equity (mrq)
394.32%
Levered Free Cash Flow (ttm)
1.44M
Research Analysis: INVO
View MoreCompany Insights: INVO
INVO does not have Company Insights